Masashi Idogawa

32PUBLICATIONS
43CO-AUTHORS
Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jan 21, 2026
Updated analysis of pathogenic variants in BRCA1/BRCA2 among the general Japanese population.

Tasuku Mariya, Masashi Idogawa, Tsuyoshi Saito

|Jan 09, 2026
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Hiroshi Yasui, Masashi Idogawa, Tadao Ishida

|Dec 11, 2025
Pan-Cancer Analysis Reveals AEBP1-Collagen Co-Expression and Its Potential Role in CAF-Mediated Tumor Stiffness.

Shohei Sekiguchi, Akira Yorozu, Megumi Watanabe

|Oct 01, 2025
Fusion Gene Detection in Driver Mutation-Negative Melanomas Using RNA-Based Anchored Multiplex Polymerase Chain Reaction.

Tokimasa Hida, Masashi Idogawa, Sayuri Sato

|Feb 08, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.

Satoshi Iyama, SungGi Chi, Masashi Idogawa

Pageof 6